What is happening at Real-World Evidence Conference
Event Goals and Offerings
Identify key events related to RWE in the past 1 year period
Compare various data standards used for the analysis and submission of real-world data
Evaluate how external control arm data can be used to inform early decisions in drug development programs
Explain the methodological approaches underlying tokenization
Describe key consideration for the use of RWD and RWE to support regulatory decision-making and apply lessons learned from recent use cases (recent approvals of RWD/RWE submissions)
Identify how to utilize clinical notes to create a representative natural language processing (NLP) training sample
Explain the need for collaborative studies to address a lack of harmonization on RWD/E methodologies and quality
Recognize trends in clinical post-marketing commitments (PMC) and requirements (PMR) issued by US FDA in oncology and how RWE can be applied
Why You Can’t Miss It
Network with like-minded professionals focused on real-world data and real-world evidence to discuss best practices and lessons learned from multiple disciplines
Intimate setting with interaction with regulators from FDA: CDER, CBER, and OCE as well as the EMA
Learn how to apply successful use cases, real-world examples, and practical outcomes into your own company or organization from regulators and industry representatives
Gain insights and discuss how stakeholders are impacted by real-world data and real-world evidence
Evaluate future applications of real-world evidence in drug development, clinical trials, and evidence generation
